Teleflex (NYSE:TFX) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Teleflex (NYSE:TFX) posted its earnings results on Thursday. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03, Zacks reports. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex updated its FY 2025 guidance to 13.950-14.350 EPS.

Teleflex Stock Down 4.7 %

Shares of NYSE:TFX opened at $132.58 on Friday. The firm’s 50 day moving average price is $175.44 and its 200 day moving average price is $205.04. The stock has a market cap of $6.16 billion, a price-to-earnings ratio of 26.36, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16. Teleflex has a fifty-two week low of $130.60 and a fifty-two week high of $249.90. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 1.03%. Teleflex’s dividend payout ratio is presently 27.04%.

Wall Street Analysts Forecast Growth

TFX has been the subject of a number of research analyst reports. Wells Fargo & Company reduced their price objective on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research report on Friday. Piper Sandler reissued a “neutral” rating and issued a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Friday. Truist Financial dropped their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Finally, Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday. Nine equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Teleflex has a consensus rating of “Hold” and an average price target of $196.83.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.